Medical technology company GE HealthCare (NASDAQ: GEHC) announced on Wednesday that it has introduced a new AI-enabled application orchestration feature, integrated into its True PACS and Centricity PACS systems, through a collaboration with Blackford.
This new offering aims to assist radiologists in managing increased workloads and exam complexities, enabling quicker diagnoses and treatments. The platform provides access to a catalog of third-party AI applications, covering areas from mammography to lung scans.
As clinician burnout rises - 49% of radiologists cited excessive bureaucratic tasks as a key issue in an RSNA survey - GE HealthCare's AI solutions focus on improving workflow efficiency. This aligns with the company's precision care framework, which integrates smart devices, targeted therapies, and digital solutions to enhance care quality.
GE HealthCare currently leads the U.S. Food and Drug Administration's (FDA) list of AI-enabled medical devices, with 80 clearances to date. The AI orchestration feature simplifies the integration of AI into clinical workflows, offering a streamlined process for healthcare providers to access and implement imaging AI solutions.
The new technology will be showcased at the Radiological Society of North America's annual meeting in Chicago from 1-4 December 2023.
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke